Genetic Analysis Market Insights 2025-2034: Growth Forecast and Strategic Priorities

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Genetic Analysis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, the genetic analysis market size has seen a swift expansion. Predictions indicate that its worth will increase from $9.09 billion in 2024 to $10.29 billion in 2025, with a compound annual growth rate (CAGR) of 13.2%. This trajectory during the historic period is the consequence of several factors including a surge in incidents of genetic and rare illnesses, amplified usage of genetic testing in cancer treatment, rising demand for tailored medical treatment and the necessity for early diagnosis and prevention of diseases. Increased cognizance about inherited diseases has also contributed to this growth.

Genetic Analysis Market Size Forecast: What's the Projected Valuation by 2029?
Expectations suggest that in the coming years, the size of the genetic analysis market will witness swift expansion. It is forecasted to escalate to a whopping $16.66 billion by 2029, experiencing a compound annual growth rate (CAGR) of 12.8%. This anticipated growth during the forecast period can be linked to the rise in newborn screening programs, its increased usage in handling chronic conditions, the burgeoning older population, the growing emphasis on genetic testing for children, and the escalating figures of lifestyle-related ailments that are genetically linked. The forthcoming period also manifests key trends like swift progression in next-generation sequencing technologies, the rise of CRISPR and other tools for gene editing, amplified bioinformatics and data interpretation tools, the utilization of AI and machine learning for analyzing genomic data, and the diminution of sequencing instruments.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genetic-analysis-global-market-report

What Are the Drivers Transforming the Genetic Analysis Market?
The surge in cancer incidences is anticipated to fuel advancement in the genetic analysis market. Cancer, characterized by unregulated cell growth with potential for metastasis, is on the rise owing to an ageing population. Elderly individuals are newly prone to genetic mutations and have experienced extended exposure to environmental and lifestyle-linked catalysts for cancer. Genetic analysis plays a pivotal role in managing cancer by detecting specific gene mutations responsible for the disease, enabling more personalized, effective treatments with lesser side effects. In May 2025, a National Cancer Institute (NCI) report revealed that nearly 20 million individuals globally received a new cancer diagnosis in 2022, and roughly 9.7 million succumbed to the disease. Predictions indicate that by 2050, the number of new annual cancer cases could reach 33 million, with cancer-related deaths rising to 18.2 million. Hence, the escalating incidences of cancer are stimulating the expansion of the genetic analysis market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27295&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Genetic Analysis Market?
Leading businesses in the genetic analysis market are concentrating on the creation of innovative solutions, including genetic testing tools, for preventive actions or early surveillance. Genetic tests examine an individual's DNA to identify changes or variations in genes that may be associated with specific health problems or inherited characteristics. For example, Devyser, a Sweden-based company that specializes in producing diagnostic kits, introduced Devyser LynchFAP and Devyser BRCA PALB2 in June 2023, two genetic testing options for hereditary cancer. Devyser LynchFAP is noteworthy for providing a comprehensive approach to examine PMS2 and an additional nine genes related to hereditary colorectal cancer, decisively tackling the intricate task of differentiating PMS2 from its pseudogene, PMS2CL. This is the first commercially available kit tailored especially for accurate analysis of the PMS2 gene. Devyser BRCA PALB2 facilitates targeted identification of genetic variations in BRCA1, BRCA2, and PALB2-genes crucially linked to a heightened risk of breast and ovarian cancer. Its streamlined design allows for easy incorporation into laboratory processes and supports DNA analysis from both blood and tumor samples within a single examination.

Which Segments in the Genetic Analysis Market Offer the Most Profit Potential?
The genetic analysis market covered in this report is segmented

1) By Product: Reagents And Kits, Instruments, Software
2) By Test: Predictive Genetic Testing, Carrier Testing, Prenatal And Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing, Other Tests
3) By Technology: Next-Generation Sequencing (NGS), Real-Time PCR System, Other Technologies
4) By Application: Cancer, Genetic Diseases, Cardiovascular Diseases, Rare Diseases, Infectious Diseases, Other Applications
5) By End-Use: Hospitals, Research And Development Laboratories, Diagnostic Centers, Other End-Uses

Subsegments:
1) By Reagents And Kits: DNA Extraction Kits, RNA Extraction Kits, PCR Reagents, Sequencing Reagents, Library Preparation Kits, Electrophoresis Reagents, Microarray Kits, Genotyping Assay Kits, Target Enrichment Kits, Nucleic Acid Labeling Kits
2) By Instruments: DNA Sequencers, PCR Machines, Microarray Scanners, Electrophoresis Systems, Real-Time PCR Systems, Automated Sample Preparation Systems, Genetic Analyzers, Bioanalyzers, Fragment Analyzers, Next-Generation Sequencing (NGS) Platforms
3) By Software: Data Analysis Software, Bioinformatics Tools, Laboratory Information Management Systems (LIMS), Genomic Data Interpretation Software, DNA Sequence Alignment Tools, Variant Annotation Software, Clinical Decision Support Software, Cloud-Based Genomic Platforms, Workflow Management Software, Data Visualization Tools

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27295&type=smp

Which Firms Dominate the Genetic Analysis Market by Market Share and Revenue in 2025?
Major companies operating in the genetic analysis market are Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Quest Diagnostics Inc., Illumina Inc., PerkinElmer Inc., BioRad Laboratories Inc., Qiagen NV, Oxford Nanopore Technologies Plc, 23andMe Inc., ELITech Group, MyHeritage Ltd., Dante Labs Inc., AutoGenomics Inc., IntegraGen SA, Family Tree DNA, 24 genetics, Centrillion Biosciences Inc., DNA Worldwide Group Ltd., and Genebase.

Which Regions Offer the Highest Growth Potential in the Genetic Analysis Market?
North America was the largest region in the genetic analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27295

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.